InnoCare OptoelectronicsTPE:6861 66 EV-to-FCF is 50.11 as of Jul. 11, 2026, which is 490% above its 10-year median of 8.50. GuruFocus rates TPE:6861 with a GF Score™ of 66/100 and a GF Value™ of NT$85.77 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 414 Medical Devices & Instruments companies, InnoCare Optoelectronics ranks worse than 79.23% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, InnoCare Optoelectronics's Enterprise Value is NT$11,413 Mil.
InnoCare Optoelectronics's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$228 Mil. Therefore, InnoCare Optoelectronics's EV-to-FCF for today is 50.11.
The historical rank and industry rank for InnoCare Optoelectronics's EV-to-FCF or its related term are showing as below:
TPE:6861'
s EV-to-FCF Range Over the Past 10 Years
Min: -39.42 Med: 8.5 Max: 203.26
Current: 56.6
During the past 8 years, the highest EV-to-FCF of InnoCare Optoelectronics was 203.26. The lowest was -39.42. And the median was 8.50.
TPE:6861's EV-to-FCF is ranked worse than 79.23% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.19
vs TPE:6861: 56.60
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
InnoCare Optoelectronics's PE Ratio (TTM) for today is calculated as:
InnoCare Optoelectronics's share price for today is NT$292.00.
InnoCare Optoelectronics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$3.790.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
InnoCare Optoelectronics EV-to-FCF Related Terms
InnoCare Optoelectronics EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, InnoCare Optoelectronics's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InnoCare Optoelectronics EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InnoCare Optoelectronics's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where InnoCare Optoelectronics's EV-to-FCF falls into.
InnoCare Optoelectronics's current Enterprise Value is NT$11,413 Mil.
InnoCare Optoelectronics's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$228 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InnoCare Optoelectronics (TPE:6861) has a EV-to-FCF of 50.11 as of Jul. 11, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on InnoCare Optoelectronics and its competitors. This is 490% above median its historical median of 8.50. According to the industry distribution chart, InnoCare Optoelectronics ranks #328 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 79.2%.
Is InnoCare Optoelectronics' EV-to-FCF too high?
InnoCare Optoelectronics' current EV-to-FCF of 50.11 is 490% above median its 10-year median of 8.50. The Medical Devices & Instruments industry median EV-to-FCF is 23.19. InnoCare Optoelectronics' value of 50.11 is 116.1% above this industry median. Based on the distribution chart, InnoCare Optoelectronics ranks #328 out of 414 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, InnoCare Optoelectronics has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InnoCare Optoelectronics' EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, InnoCare Optoelectronics ranks #328 out of 414 companies for EV-to-FCF. This places InnoCare Optoelectronics in the lower half of its industry. The industry median EV-to-FCF is 23.19. InnoCare Optoelectronics' value of 50.11 is 116.1% above this benchmark. While the company's 10-year median is 8.50 vs. the industry median of 23.19, InnoCare Optoelectronics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.19, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InnoCare Optoelectronics's current EV-to-FCF of 50.11 is 116.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on InnoCare Optoelectronics and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InnoCare Optoelectronics's current EV-to-FCF is 50.11, which is 490% above median its own 10-year median of 8.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InnoCare Optoelectronics stock overvalued right now?
Based on GuruFocus' analysis, InnoCare Optoelectronics (TPE:6861) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$85.77, compared to a current price of NT$292.00 — trading 240.4% above its estimated fair value. The current EV-to-FCF is 50.11, which is 490% above median its 10-year median of 8.50 and 116.1% above the Medical Devices & Instruments industry median of 23.19. InnoCare Optoelectronics' overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For InnoCare Optoelectronics (TPE:6861), the current EV-to-FCF is 50.11 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InnoCare Optoelectronics (TPE:6861) Overvalued in 2026?
Based on GuruFocus' analysis, InnoCare Optoelectronics stock appears to be overvalued.
The current stock price of NT$292.00 is trading 240.4% above its estimated GF Value™ of NT$85.77.
GuruFocus considers InnoCare Optoelectronics to be Significantly Overvalued.
Key valuation signals for TPE:6861:
EV-to-FCF: 50.11 (490% above median its 10-year median of 8.50)
GF Value™: NT$85.77 vs. price of NT$292.00 (240.4% above fair value)
Industry Position: 116.1% above the Medical Devices & Instruments median (#328 of 414)
No single metric tells the full story. See the TPE:6861 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InnoCare Optoelectronics Corp is mainly engaged in the manufacturing and sale of optical instruments and medical equipment. Its products include X-Ray flat panel detector devices, X-Ray flat panel detector modules, and others.
66GF Score
Get the complete analysis for TPE:6861
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6861 has been successfully added to your 
